Re: Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers Response

被引：0
|
作者：
Narod, Steven A. [1 ]
机构：
[1] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 04期
关键词：
ORAL-CONTRACEPTIVES;
D O I：
10.1093/jnci/djn474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 278
页数：2
相关论文
共 50 条
  • [1] Re: Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
    Eisinger, Francois
    Huiart, Laetitia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (04):
  • [2] Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers
    Eisen, Andrea
    Lubinski, Jan
    Gronwald, Jacek
    Moller, Pal
    Lynch, Henry T.
    Klijn, Jan
    Kim-Sing, Charmaine
    Neuhausen, Susan L.
    Gilbert, Lucy
    Ghadirian, Parviz
    Manoukian, Siranoush
    Rennert, Gad
    Friedman, Eitan
    Isaacs, Claudine
    Rosen, Eliot
    Rosen, Barry
    Daly, Mary
    Sun, Ping
    Narod, Steven A.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (19) : 1361 - 1367
  • [3] RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Response
    Kotsopoulos, Joanne
    Sun, Ping
    Narod, Steven
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (10):
  • [4] Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Karlan, Beth Y.
    Huzarski, Tomasz
    Tung, Nadine
    Moller, Pal
    Armel, Susan
    Lynch, Henry T.
    Senter, Leigha
    Eisen, Andrea
    Singer, Christian F.
    Foulkes, William D.
    Jacobson, Michelle R.
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    JAMA ONCOLOGY, 2018, 4 (08) : 1059 - 1065
  • [5] Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Hopper, JL
    Baron, JA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) : 1010 - 1011
  • [6] RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Nolan, Emma
    Vaillant, Francois
    Visvader, Jane E.
    Lindeman, Geoffrey J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (10):
  • [7] Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, J
    Lubinski, J
    Neuhausen, SL
    Lynch, HT
    Rosen, B
    Ainsworth, P
    Moller, P
    Ghadirian, P
    Isaacs, C
    Karlan, B
    Sun, P
    Narod, SA
    GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 83 - 88
  • [8] OCs increase breast cancer risk in BRCA1 mutation carriers
    Reactions Weekly, 2003, 935-936 (1) : 3 - 3
  • [9] Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study
    Joanne Kotsopoulos
    Tomasz Huzarski
    Jacek Gronwald
    Pal Moller
    Henry T. Lynch
    Susan L. Neuhausen
    Leigha Senter
    Rochelle Demsky
    William D. Foulkes
    Charis Eng
    Beth Karlan
    Nadine Tung
    Christian F. Singer
    Ping Sun
    Jan Lubinski
    Steven A. Narod
    Breast Cancer Research and Treatment, 2016, 155 : 365 - 373
  • [10] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Kelly Metcalfe
    Henry T. Lynch
    Parviz Ghadirian
    Nadine Tung
    Charmaine Kim-Sing
    Olufunmilayo I. Olopade
    Susan Domchek
    Andrea Eisen
    William D. Foulkes
    Barry Rosen
    Danny Vesprini
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2011, 127 : 287 - 296
12345